135 related articles for article (PubMed ID: 32347657)
1. Genetic polymorphisms of pharmacogenomic VIP variants in the Dai population from Yunnan province.
Cheng Y; Dai R; Chen W; Li Q; Zhang C; Yang T
Mol Genet Genomic Med; 2020 Jul; 8(7):e1231. PubMed ID: 32347657
[TBL] [Abstract][Full Text] [Related]
2. Genetic analysis of pharmacogenomic VIP variants in the Blang population from Yunnan Province of China.
Zhang C; Guo W; Cheng Y; Li Q; Yang X; Dai R; Zhu L; Chen W
Mol Genet Genomic Med; 2019 May; 7(5):e574. PubMed ID: 30955239
[TBL] [Abstract][Full Text] [Related]
3. Genetic polymorphisms analysis of pharmacogenomic VIP variants in Bai ethnic group from China.
Chen W; Ding H; Cheng Y; Li Q; Dai R; Yang X; Zhang C
Mol Genet Genomic Med; 2019 Sep; 7(9):e884. PubMed ID: 31361092
[TBL] [Abstract][Full Text] [Related]
4. Genetic polymorphisms of pharmacogenomic VIP variants in the Kyrgyz population from northwest China.
Yunus Z; Liu L; Wang H; Zhang L; Li X; Geng T; Kang L; Jin T; Chen C
Gene; 2013 Oct; 529(1):88-93. PubMed ID: 23954225
[TBL] [Abstract][Full Text] [Related]
5. Genetic analysis of pharmacogenomic VIP variants in the Wa population from Yunnan Province of China.
Li D; Peng L; Xing S; He C; Jin T
BMC Genom Data; 2021 Nov; 22(1):51. PubMed ID: 34798807
[TBL] [Abstract][Full Text] [Related]
6. Genetic polymorphisms of pharmacogenomic VIP variants in the Lahu population from Yunnan Province.
Dou X; Yang S; Zhang W; Meng W; Zhao W; Hao J; Hu X; Guo L; Jin T
Gene; 2022 Nov; 844():146825. PubMed ID: 35995116
[TBL] [Abstract][Full Text] [Related]
7. Very important pharmacogenetic variants landscape and potential clinical relevance in the Zhuang population from Yunnan province.
Li Y; Chang Y; Yan Y; Ma X; Zhou W; Zhang H; Guo J; Wei J; Jin T
Sci Rep; 2024 Mar; 14(1):7495. PubMed ID: 38553524
[TBL] [Abstract][Full Text] [Related]
8. Genetic polymorphisms in very important pharmacogenomic variants in the Zhuang ethnic group of Southwestern China: A cohort study in the Zhuang population.
Li J; Guo C; Yan M; Niu F; Chen P; Li B; Jin T
Medicine (Baltimore); 2018 Apr; 97(17):e0559. PubMed ID: 29703042
[TBL] [Abstract][Full Text] [Related]
9. Analysis of Very Important Pharmacogenomics Variants in the Chinese Lahu Population.
Cheng Y; Li Q; Yang X; Ding H; Chen W; Dai R; Zhang C
Pharmgenomics Pers Med; 2021; 14():1275-1289. PubMed ID: 34629888
[TBL] [Abstract][Full Text] [Related]
10. The landscape of very important pharmacogenes variants and potential clinical relevance in the Chinese Jingpo population: a comparative study with worldwide populations.
Ma X; Li Y; Zang X; Guo J; Zhou W; Han J; Liang J; Wan P; Yang H; Jin T
Cancer Chemother Pharmacol; 2024 May; 93(5):481-496. PubMed ID: 38300251
[TBL] [Abstract][Full Text] [Related]
11. AI-SNPs screening based on the whole genome data and research on genetic structure differences of subcontinent populations.
Wang HY; Hu YH; Cao YY; Zhu Q; Huang YG; Li X; Zhang J
Yi Chuan; 2021 Oct; 43(10):938-948. PubMed ID: 34702706
[TBL] [Abstract][Full Text] [Related]
12. Genetic polymorphisms study of pharmacogenomic VIP variants in Han ethnic of China's Shaanxi province.
Jin T; Zhao R; Shi X; He N; He X; Ouyang Y; Wang H; Wang B; Kang L; Yuan D
Environ Toxicol Pharmacol; 2016 Sep; 46():27-35. PubMed ID: 27414743
[TBL] [Abstract][Full Text] [Related]
13. Genetic polymorphisms of pharmacogenomic VIP variants in Li nationality of southern China.
Ding Y; He P; He N; Li Q; Sun J; Yao J; Yi S; Xu H; Wu D; Wang X; Jin T
Environ Toxicol Pharmacol; 2016 Mar; 42():237-42. PubMed ID: 26901752
[TBL] [Abstract][Full Text] [Related]
14. Genetic Polymorphisms of Very Important Pharmacogene Variants in the Blang Population from Yunnan Province in China.
Wang Y; Peng L; Lu H; Zhang Z; Xing S; Li D; He C; Jin T; Wang L
Pharmgenomics Pers Med; 2021; 14():1647-1660. PubMed ID: 34949935
[TBL] [Abstract][Full Text] [Related]
15. Genetic polymorphisms of pharmacogenomic VIP variants in the Yi population from China.
Yan M; Li D; Zhao G; Li J; Niu F; Li B; Chen P; Jin T
Gene; 2018 Mar; 648():54-62. PubMed ID: 29337087
[TBL] [Abstract][Full Text] [Related]
16. Population genetic difference of pharmacogenomic VIP gene variants in the Lisu population from Yunnan Province.
Zhang C; Jiang X; Chen W; Li Q; Yun F; Yang X; Dai R; Cheng Y
Medicine (Baltimore); 2018 Dec; 97(52):e13674. PubMed ID: 30593137
[TBL] [Abstract][Full Text] [Related]
17. Genetic polymorphisms of pharmacogenomic VIP variants in the Hui population from Ningxia Province of China.
Zhou W; Guo J; Li Y; Ma X; Yang S; Wei J; Zhang H; Zhang S; Jin T
Funct Integr Genomics; 2023 Mar; 23(2):85. PubMed ID: 36930384
[TBL] [Abstract][Full Text] [Related]
18. Genetic polymorphisms of pharmacogenomic VIP variants in the lhoba population of southwest China.
He Y; Yang H; Geng T; Feng T; Yuan D; Kang L; Luo M; Jin T
Int J Clin Exp Pathol; 2015; 8(10):13293-303. PubMed ID: 26722533
[TBL] [Abstract][Full Text] [Related]
19. Pharmacogenomic landscape of VIP genetic variants in Jordanian Arabs and comparison with worldwide populations.
Al-Eitan LN
Gene; 2020 May; 737():144408. PubMed ID: 32007583
[TBL] [Abstract][Full Text] [Related]
20. Analysis of very important pharmacogene variants in the Tibetan population from China.
Rong H; Dong H; He X; Yuan D; Bai M; Wang L; Liu T; He Y; Zheng J; Wang Y; Jin T
Clin Exp Pharmacol Physiol; 2021 May; 48(5):668-678. PubMed ID: 32311112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
